{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:03:50Z","timestamp":1776132230379,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T00:00:00Z","timestamp":1460073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T00:00:00Z","timestamp":1460073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2016.18","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T17:39:01Z","timestamp":1460137141000},"page":"e413-e413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML"],"prefix":"10.1038","volume":"6","author":[{"given":"K","family":"Krysiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z L","family":"Skidmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R T","family":"Demeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kunisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"O'Laughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E J","family":"Duncavage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C A","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B A","family":"Ozenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L D","family":"Wartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O L","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"BFbcj201618_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/sj.leu.2403607","volume":"19","author":"U Bacher","year":"2004","unstructured":"Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T et al. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia 2004; 19: 460\u2013463.","journal-title":"Leukemia"},{"key":"BFbcj201618_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1182\/blood-2002-07-2053","volume":"101","author":"T Bumm","year":"2002","unstructured":"Bumm T . Emergence of clonal cytogenetic abnormalities in Ph-cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. Blood 2002; 101: 1941\u20131949.","journal-title":"Blood"},{"key":"BFbcj201618_CR3","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/sj.leu.2403399","volume":"18","author":"C Terre","year":"2004","unstructured":"Terre C, Eclache V, Rousselot P, Imbert M, Charrin C, Gervais C et al. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia 2004; 18: 1340\u20131346.","journal-title":"Leukemia"},{"key":"BFbcj201618_CR4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/cncr.22936","volume":"110","author":"MWN Deininger","year":"2007","unstructured":"Deininger MWN, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M et al. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells. Cancer 2007; 110: 1509\u20131519.","journal-title":"Cancer"},{"key":"BFbcj201618_CR5","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","volume":"108","author":"C Kovitz","year":"2006","unstructured":"Kovitz C, Kantarjian H, Garcia-Manero G, Abruzzo LV, Cortes J . Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood 2006; 108: 2811\u20132813.","journal-title":"Blood"},{"issue":"Suppl","key":"BFbcj201618_CR6","first-page":"ECR25","volume":"90","author":"JM Perel","year":"2005","unstructured":"Perel JM, McCarthy C, Walker O, Irving I, Williams B, Kennedy GA . Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate. Haematologica 2005; 90, (Suppl) ECR25.","journal-title":"Haematologica"},{"key":"BFbcj201618_CR7","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/leu.2014.272","volume":"28","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Rinke J, Sch\u00e4fer V, Schnittger S, Kohlmann A, Obstfelder E et al. Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status. Leukemia 2014; 28: 2292\u20132299.","journal-title":"Leukemia"},{"key":"BFbcj201618_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jama.2015.9643","volume":"314","author":"JM Klco","year":"2015","unstructured":"Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S et al. Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia. JAMA 2015; 314: 811\u2013822.","journal-title":"JAMA"},{"key":"BFbcj201618_CR9","doi-asserted-by":"publisher","first-page":"e1004274","DOI":"10.1371\/journal.pcbi.1004274","volume":"11","author":"M Griffith","year":"2015","unstructured":"Griffith M, Griffith OL, Smith SM, Ramu A, Callaway MB, Brummett AM et al. Genome modeling system: a knowledge management platform for genomics. PLoS Comput Biol 2015; 11: e1004274.","journal-title":"PLoS Comput Biol"},{"key":"BFbcj201618_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cancergencyto.2010.02.005","volume":"199","author":"N Larsson","year":"2010","unstructured":"Larsson N, Billstrom R, Lilljebjorn H, Lassen C, Richter J, Ekblom M et al. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells. Cancer Genet Cytogenet 2010; 199: 89\u201395.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFbcj201618_CR11","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1182\/blood-2011-07-365320","volume":"118","author":"V Grossmann","year":"2011","unstructured":"Grossmann V, Tiacci E, Holmes AB, Kohlmann A, Martelli MP, Kern W et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood 2011; 118: 6153\u20136163.","journal-title":"Blood"},{"key":"BFbcj201618_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","volume":"150","author":"JS Welch","year":"2012","unstructured":"Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 2012; 150: 264\u2013278.","journal-title":"Cell"},{"key":"BFbcj201618_CR13","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059\u20132074.","journal-title":"N Engl J Med"},{"key":"BFbcj201618_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/leu.2014.144","volume":"29","author":"A Kurtovic-Kozaric","year":"2015","unstructured":"Kurtovic-Kozaric A, Przychodzen B, Singh J, Konarska MM, Clemente MJ, Otrock ZK et al. PRPF8 defects cause missplicing in myeloid malignancies. Leukemia 2015; 29: 126\u2013136.","journal-title":"Leukemia"},{"key":"BFbcj201618_CR15","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/leu.2011.280","volume":"26","author":"G Georgiou","year":"2012","unstructured":"Georgiou G, Efthymiou A, Vardounioti I, Boutsikas G, Angelopoulou MK, Vassilakopoulos TP et al. Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib. Leukemia 2012; 26: 824\u2013826.","journal-title":"Leukemia"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201618","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:06:06Z","timestamp":1672823166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,8]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4]]}},"alternative-id":["BFbcj201618"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2016.18","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,8]]},"assertion":[{"value":"8 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}